Table 2 Data assessment schedule in the PROLUCA trial
From: Perioperative rehabilitation in operation for lung cancer (PROLUCA) – rationale and design
Baselinea | Flw-upb | Flw-upc | Flw-upd | Flw-upe | Flw-upf | |
|---|---|---|---|---|---|---|
Anthropometric data and cancer disease | X | X | X | X | X | |
Physiological measurements | ||||||
Cardiorespiratory capacity (VO2peak) | X | X | X | X | X | |
Six- minute walk distance (6MWD) | X | X | X | X | X | X |
One-repetition-maximum (1RM) | X | X | X | X | X | |
Heart rate (HR), Blood pressure (BP) | X | X | X | X | X | |
Spirometric (FEV1/FEV1%) | X | X | X | X | X | |
Patient-reported outcome | ||||||
Health-related quality of life (EORTC QLQ-C30, FACT-L) | X | X | FACT-L | X | X | X |
Symptoms and side effects (EORTC–LC13) | X | X | X | X | X | |
Anxiety and depression (HADS) | X | X | X | X | X | |
Well-being (SF-36) | X | X | X | X | X | |
Distress thermometer | X | X | X | X | X | |
Lifestyle | X | X | X | X | X | |
Sickness absence and work status | X | X | X | X | X | |
Social support (MSPSS) | X | X | X | X | X | |
Other measurements | ||||||
Perioperative complications | X (30 days) | X (30 days) | ||||
Duration of hospitalization | X (30 days) | X (30 days) | ||||
Survival Histological diagnosis and TNM staging | X | |||||